Information For Health Professionals on
Influenza A Variant Viruses H3N2v and H1N2v
Healthcare Providers, ask patients with influenza-like illness (ILI) whether they have had recent exposure to birds or swine. Clinicians are reminded to consider influenza as a possible diagnosis when evaluating patients with acute respiratory illnesses, including pneumonia, even outside of the typical influenza season.
Contact MDH to report suspect cases, and to arrange testing prior to specimen submission.
- More information for health professionals regarding specimen collection, submission, and treatment for influenza.
Seasonal Flu Information for Health Professionals | Information For Health Professionals on Novel Influenza A Virus (H7N9)
Surveillance, Reporting, Specimen Collection and Testing
- Providers should call MDH at 651-201-5414 or toll-free at 1-877-676-5414 to report suspect cases.
- Specimen Collection and Testing for Influenza A Variant Viruses H3N2v and H1N2v
Criteria and process for specimen collection and testing for Influenza A Variant Viruses H3N2v and H1N2v
H3N2v and H1N2v
- Commercially available rapid influenza diagnostic tests (RIDTs) may not detect H3N2v or H1N2v virus in respiratory specimens. MDH is prepared to conduct RT-PCR testing on patients with ILI who meet any of the following criteria:
- Hospitalized with no other diagnosis for ILI
- Recent (7 days or less) contact with swine
- Recent (7 days or less) attendance at a county or agricultural fair at which swine are present
- Recent contact with someone with ILI who had recent exposure to swine
MDH is also conducting enhanced surveillance through established sentinel influenza surveillance sites.
Use of Rapid Influenza Diagnostic Testing
- (Updated Case Count and) Evaluation of Rapid Influenza Diagnostic Tests for Influenza A (H3N2)v Virus Infections – United States, 2012 (PDF). CDC Morbidity and Mortality Weekly Report 2012. Early Release August 10, 2012. Attention: Non-MDH link
Treatment
- H3N2v and H1N2v are considered susceptible to antiviral agents oseltamivir (Tamiflu) and zanamivir (Relenza).
Further information on diagnosis and treatment
- CDC: Information on Influenza A(H3N2)v
Background, case count, protection measures, and other resources.
Attention: Non-MDH links
- More information for health professionals regarding specimen collection, submission, and treatment for influenza.
Seasonal Flu Information for Health Professionals | Information For Health Professionals on Novel Influenza A Virus (H7N9)



